Clinical use of dipeptidyl peptidase-4 and sodium-glucose cotransporter 2 inhibitors in combination therapy for type 2 diabetes mellitus
Author:
Affiliation:
1. The Ohio State University, Columbus, OH, USA
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/00325481.2015.1044756
Reference104 articles.
1. American Diabetes Association . Fast facts: data and statistics about diabetes. Available from http://professional.diabetes.org/admin/UserFiles/0%20-%20Sean/14_fast_facts.pdf. Last accessed 16 March 2015
2. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
3. Centers for Disease Control and Prevention . National diabetes statistics report: estimates of diabetes and its burden in the United States. 2014. Available from http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Last accessed 16 March 2015
4. In This Issue of Diabetes Care
5. American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement - Executive Summary
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin;Cureus;2024-04-12
2. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2019-04-18
3. Diabetes pharmacotherapy and effects on the musculoskeletal system;Diabetes/Metabolism Research and Reviews;2018-12-20
4. Dapagliflozin and saxagliptin tablets for adults with type 2 diabetes;Expert Review of Clinical Pharmacology;2017-10-18
5. Pharmacokinetic drug evaluation of saxagliptin plus dapagliflozin for the treatment of type 2 diabetes;Expert Opinion on Drug Metabolism & Toxicology;2017-04-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3